Skip to main content

Advertisement

SpringerLink
Log in

Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

To review the outcomes of pelvic exenterative surgery done with a palliative intent and evaluate its role in relapsed gynaecology malignancies.

Method

This is a retrospective cohort study between April 2009 and May 2012 in Oxford Gynaecological Cancer Centre. Patients were identified from the oncology surgical database.

Results

18 patients were identified with a mean age 54 (26–79) years, who underwent surgery for symptomatic recurrent cancer. All except one patient had radiotherapy prior to surgery. 12 patients had cervical cancer, five had vulval cancer and one had endometrial cancer. About half of the patients had major surgical complications; however, majority was patients satisfied with the outcome.

Conclusion

Pelvic exenteration in this context carries considerable morbidity and in this series achieved good symptom control with a mean overall survival of 11 months. Careful patient selection, adequate counselling and ongoing support are imperative of successful outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Reference

  1. Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma. Cancer 1:177–183

    Article  CAS  PubMed  Google Scholar 

  2. Magrina JF (1990) Types of pelvic exenterations: a reappraisal. Gynecol Oncol 37:363–366

    Article  CAS  PubMed  Google Scholar 

  3. Brunschwig A (1965) What are the indications and results of pelvic exenteration? JAMA 194:274

    Article  CAS  PubMed  Google Scholar 

  4. Höckel M, Dornhöfer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7(10):837–847

    Article  PubMed  Google Scholar 

  5. Turns D (2001) Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 76:224–236

    Article  CAS  PubMed  Google Scholar 

  6. Roos EJ, de Graeff A, van Eijkeren MA et al (2004) Quality of life after pelvic exenteration. Gynecol Oncol 93:610–614

    Article  CAS  PubMed  Google Scholar 

  7. Hawighorst-Knapstein S, Fusshoeller C, Franz C et al (2004) The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol 94:398–403

    Article  PubMed  Google Scholar 

  8. Kiselow M, Butcher HR Jr, Bricker EM (1967) Results of the radical surgical treatment of advanced pelvic cancer: a fifteen-year study. Ann Surg 166:428–436

    CAS  PubMed  Google Scholar 

  9. Ingiulla W, Cosmi EV (1967) Pelvic exenteration for advanced carcinoma of the cervix: some reflections on 241 cases. Am J Obstet Gynecol 99:1083–1086

    CAS  PubMed  Google Scholar 

  10. Ketcham AS, Deckers PJ, Sugarbaker EV et al (1970) Pelvic exenteration for carcinoma of the uterine cervix: a 15-year experience. Cancer 26:513–521

    Article  CAS  PubMed  Google Scholar 

  11. Symmonds RE, Pratt JH, Webb MJ (1975) Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 121:907–918

    CAS  PubMed  Google Scholar 

  12. Averette HE, Lichtinger M, Sevin BU, Girtanner RE (1984) Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 150:179–184

    Article  CAS  PubMed  Google Scholar 

  13. Lambrou NC, Pearson JM, Averette HE (2005) Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations. Surg Oncol Clin N Am 14:289–300

    Article  PubMed  Google Scholar 

  14. Sharma S, Odunsi K, Driscoll D, Lele S (2005) Pelvic exenteration for gynecological malignancies: twenty-year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer 15:475–482

    Article  CAS  PubMed  Google Scholar 

  15. Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynaecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99(1):1539

    Article  Google Scholar 

  16. Hockel M (2003) Laterally extended endopelvic resection novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol 91:369–377

    Article  PubMed  Google Scholar 

  17. Magrina JF, Stanhope CR, Waever AL (1997) Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol 64:130–135

    Article  CAS  PubMed  Google Scholar 

  18. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA (1989) Pelvic exenteration, university of Michigan: 100 patients at 5 years. Obstet Gynecol 74:934–943

    CAS  PubMed  Google Scholar 

  19. Rutledge FN, Smith JP, Wharton JT, O’Quinn AG (1977) Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 129:881–892

    CAS  PubMed  Google Scholar 

  20. Hockel M, Dornhofer N (2006) Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7(10):837–847

    Article  PubMed  Google Scholar 

  21. Deckers PJ, Ketcham AS, Sugarbaker EV, Hoye RC, Thomas LB (1971) Pelvic exenteration for primary carcinoma of the uterine cervix. Obstet Gynecol 37(5):647–659

    CAS  PubMed  Google Scholar 

  22. Bricker EM (1950) Bladder substitution after pelvic evisceration. Surg Clin North Am 30(5):1511–1521

    CAS  PubMed  Google Scholar 

  23. Orr JW Jr, Shingleton HM, Hatch KD et al (1982) Urinary diversion in patients undergoing pelvic exenteration. Am J Obstet Gynecol 142:883–889

    PubMed  Google Scholar 

  24. Ghulam N, McClinton S, Yong SM et al (2005) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev 2:CD003306

    Google Scholar 

  25. Dottino PR, Segna RA, Jennings TS et al (1994) The stapled continent ileocecal urinary reservoir in the surgical management of gynecologic malignancy. Gynecol Oncol 55:185–189

    Article  CAS  PubMed  Google Scholar 

  26. Goldberg GL, Sukumvanich P, Einstein MH et al (2006) Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003). Gynecol Oncol 101:261–268

    Article  PubMed  Google Scholar 

  27. Hatch KD, Gelder MS, Soong SJ et al (1990) Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol Oncol 38:462–467

    Article  CAS  PubMed  Google Scholar 

  28. Moutardier V, Houvenaeghel G, Lelong B et al (2003) Colorectal function preservation in posterior and total supralevator exenteration for gynecologic malignancies: an 89-patient series. Gynecol Oncol 89:155–159

    Article  CAS  PubMed  Google Scholar 

  29. Roos EJ, de Graeff A, van Eijkeren MA et al (2004) Quality of life after pelvic exenteration. Gynecol Oncol 93:610–614

    Article  CAS  PubMed  Google Scholar 

  30. Hawighorst-Knapstein S, Fusshoeller C, Franz C et al (2004) The impact of treatment for genital cancer on quality of life and body image: results of a prospective longitudinal 10-year study. Gynecol Oncol 94:398–403

    Article  PubMed  Google Scholar 

  31. Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I et al (2011) Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol 122:14–18

    Article  CAS  PubMed  Google Scholar 

  32. Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A (2012) Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J Surg Oncol 38(10):948–954

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Oxford University Hospital, Headington, Oxford, OX3 7LJ, UK

    P. Pathiraja, H. Sandhu, M. Instone, K. Haldar & S. Kehoe

Authors
  1. P. Pathiraja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Sandhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Instone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Haldar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Kehoe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Pathiraja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pathiraja, P., Sandhu, H., Instone, M. et al. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?. Arch Gynecol Obstet 289, 657–662 (2014). https://doi.org/10.1007/s00404-013-3023-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-3023-5

Keywords

Search

Navigation